Search Job Title Only
News By Subject
News by Disease
News By Date
Get Our FREE
)'s Avandia - When a Drug is on The Market, But Not Really; Drug Officially Gone From US Pharmacies in November
5/19/2011 8:13:25 AM
GlaxoSmithKline Plc (GSK)’s diabetes drug Avandia will be pulled from U.S. pharmacies in November and available only through a special program, the Food and Drug Administration said. The restrictions are part of a risk mitigation strategy established in September with a medication guide to limit the use of Avandia after data suggested patients had a higher chance of heart attacks. The drug and combination therapies containing it will no longer be available in retail pharmacies starting Nov. 18, according to the FDA, which is requiring doctors and patients to enroll in a program to prescribe or take them.
Los Angeles Times
Isis Pharmaceuticals, Inc.
(ISIS) Initiates Phase 1 Study of ISIS-TTRRx and Earns $5 Million Milestone Payment From
Over Misleading Promotion
(GSK) Pharma Q1 Profit Drops On One-Time Charge
Johnson & Johnson
(JNJ) Recalls HIV Drug After Finding Smelly Chemical
(SASY.PA) Shortens Name to
and Slows Down Buyouts; Isn't Interested in Buying
(GSK)'s Alli, CEO Says
Bristol-Myers Squibb Company
(BMY) Initiates a Nationwide Voluntary Recall of Coumadin
(GSK) Hook up with Academia for Inflammation Research and Creates Inflammation Research Centre
American Regent, Inc.
Initiates Nationwide Voluntary Recall of Caffeine & Sodium Benzoate Injection, USP 250 mg/mL, 2 mL Single Dose Vial Due to Visible Particulates
(GSK) CEO Says No Short-Term Plan to Divest HIV Unit
Sees Safety Issue with
Merck & Co., Inc.
(MRK) Hepatitis Drug
comments powered by Disqus.
comments powered by
Los Angeles Times
Clinical - Recalls and Warnings